{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:19:06Z","timestamp":1789834746449,"version":"4.0.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Antifungal therapy is a common treatment option for pulmonary aspergillosis, but its use to prevent recurrence and relieve symptoms in patients with pulmonary aspergillosis remains controversial. This study aimed to explore the short-term efficacy and cost of itraconazole vs. voriconazole in the treatment of pulmonary aspergillosis during the perioperative period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively collected the clinical data of 55 patients with pulmonary aspergillosis who underwent surgery and received itraconazole or voriconazole as antifungal therapy between January 1, 2016, and October 31, 2022, at the Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University. We analyzed the effects of different antifungal therapies on the incidence of adverse events, short-term efficacy, and cost-effectiveness of pulmonary aspergillosis treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Except for the younger average age of patients in the itraconazole group, there were no significant differences in baseline characteristics such as sex, BMI, underlying lung disease, accompanying symptoms, and lesion location between the voriconazole and itraconazole groups. There was no significant difference in the incidence of adverse events or short-term efficacy, including recovery, symptom improvement, and recurrence rates, during the administration of the antifungal regimens between the two groups. Regarding economic cost efficiency, there was no significant difference in the median hospitalization costs between the two groups. However, despite the longer antifungal treatment duration in the itraconazole group, the cost of itraconazole was significantly lower than that of voriconazole.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Both itraconazole and voriconazole effectively prevented the recurrence of pulmonary aspergillosis. They are similar in terms of the incidence of adverse events and short-term efficacy; however, itraconazole is more economical.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2025.1553699","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:27:11Z","timestamp":1744003631000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Observational study of the recent efficacy and economy of itraconazole vs. voriconazole in perioperative pulmonary aspergillosis"],"prefix":"10.3389","volume":"12","author":[{"given":"Peng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhe","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixian","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/jof6020075","article-title":"Chronic pulmonary aspergillosis: notes for a clinician in a resource-limited setting where there is no mycologist","volume":"6","author":"Bongomin","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S1473-3099(22)00057-3","article-title":"Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India","volume":"22","author":"Sehgal","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.2471\/BLT.11.089441","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis","volume":"89","author":"Denning","year":"2011","journal-title":"Bull World Health Organ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2169\/internalmedicine.52.9142","article-title":"Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis","volume":"52","author":"Nakamoto","year":"2013","journal-title":"Intern Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40121-020-00315-4","article-title":"Pulmonary aspergillosis: an evolving challenge for diagnosis and treatment","volume":"9","author":"Russo","year":"2020","journal-title":"Infect Dis Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"101041","DOI":"10.1016\/j.mycmed.2020.101041","article-title":"Clinical features and outcome of patients with chronic pulmonary aspergillosis in China: a retrospective, observational study","volume":"30","author":"Niu","year":"2020","journal-title":"J Mycol Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/myc.12152","article-title":"Chronic pulmonary aspergillosis","volume":"57","author":"Schweer","year":"2014","journal-title":"Mycoses"},{"key":"B8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5603\/ARM.2019.0061","article-title":"Advances in the diagnosis and management of pulmonary aspergillosis","volume":"87","author":"Gao","year":"2019","journal-title":"Adv Respir Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jinf.2015.11.003","article-title":"Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)","volume":"72","author":"Page","year":"2016","journal-title":"J Infect"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/s12879-019-4303-x","article-title":"Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis","volume":"19","author":"Ma","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.rmed.2018.06.029","article-title":"The spectrum of pulmonary aspergillosis","volume":"141","author":"Kanj","year":"2018","journal-title":"Respir Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jinf.2014.01.005","article-title":"Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis","volume":"68","author":"Shin","year":"2014","journal-title":"J Infect"},{"key":"B16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/myc.12103","article-title":"Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR","volume":"57","author":"Fraczek","year":"2014","journal-title":"Mycoses"},{"key":"B17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/17476348.2020.1750956","article-title":"An overview of the available treatments for chronic cavitary pulmonary aspergillosis","volume":"14","author":"Sehgal","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"105903","DOI":"10.1016\/j.rmed.2020.105903","article-title":"Non-surgical treatment options for pulmonary aspergilloma","volume":"164","author":"Lang","year":"2020","journal-title":"Respir Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1086\/657306","article-title":"Efficacy and safety of posaconazole for chronic pulmonary aspergillosis","volume":"51","author":"Felton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000489474","article-title":"Treatment of chronic pulmonary aspergillosis: current standards and future perspectives","volume":"96","author":"Alastruey-Izquierdo","year":"2018","journal-title":"Respiration"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0240374","DOI":"10.1371\/journal.pone.0240374","article-title":"Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: a systematic review and meta-analysis","volume":"15","author":"Olum","year":"2020","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s12281-017-0304-7","article-title":"The management of chronic pulmonary aspergillosis: the UK national aspergillosis centre approach","volume":"11","author":"Maghrabi","year":"2017","journal-title":"Curr Fungal Infect Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/myc.13131","article-title":"Intravenous therapy for chronic pulmonary aspergillosis: a systematic review and meta-analysis","volume":"63","author":"Bongomin","year":"2020","journal-title":"Mycoses"},{"key":"B24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.athoracsur.2021.06.074","article-title":"Surgical treatment of pulmonary aspergilloma: a 13-year experience from a single clinical center","volume":"114","author":"Jiang","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12890-022-01836-z","article-title":"Outcomes of surgery for different types of chronic pulmonary aspergillosis: results from a single-center, retrospective cohort study","volume":"22","author":"Shen","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/1749-8090-8-180","article-title":"Results of surgery for chronic pulmonary aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence\u2014a national centre\u2019s experience","volume":"8","author":"Farid","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1749-8090-6-129","article-title":"Cavernostomy x resection for pulmonary aspergilloma: a 32-year history","volume":"6","author":"Cesar","year":"2011","journal-title":"J Cardiothorac Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.athoracsur.2005.03.078","article-title":"Clinical profile and surgical outcome for pulmonary aspergilloma: a single center experience","volume":"80","author":"Akbari","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/thx.38.8.572","article-title":"Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment","volume":"38","author":"Jewkes","year":"1983","journal-title":"Thorax"},{"key":"B30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12893-015-0103-4","article-title":"Lung resection in pulmonary aspergilloma: experience of a Moroccan center","volume":"15","author":"Hammoumi MM","year":"2015","journal-title":"BMC Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ejcts.2005.02.008","article-title":"Complex pulmonary aspergilloma treated with single stage cavernostomy and myoplasty","volume":"27","author":"Gebitekin","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.athoracsur.2010.02.037","article-title":"Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy","volume":"89","author":"Sagan","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/cid\/cit411","article-title":"Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis","volume":"57","author":"Al-Shair","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1378\/chest.06-2441","article-title":"Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients","volume":"131","author":"Camuset","year":"2007","journal-title":"Chest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s10096-012-1690-y","article-title":"Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial","volume":"31","author":"Cadranel","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"B37","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1093\/mmy\/myy070","article-title":"Chronic pulmonary aspergillosis update: a year in review","volume":"57","author":"Barac","year":"2019","journal-title":"Med Mycol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11748-018-0904-3","article-title":"Feasibility of surgery for pulmonary aspergilloma: analysis of the operative modes","volume":"66","author":"Komori","year":"2018","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12890-021-01702-4","article-title":"The effects of antifungal therapy on the recurrence of aspergillus infection after pulmonary aspergilloma resection: a study protocol for a single-center, prospective, non-blind, randomized, 24-month, parallel group study","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Pulm Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/0003-4975(92)90086-j","article-title":"Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment","volume":"54","author":"Massard","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"B41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0022-5223(19)42051-5","article-title":"The surgical implications of intracavitary mycetomas (fungus balls)","volume":"62","author":"Solit","year":"1971","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/000313480707300317","article-title":"Thoracoscopic lingulectomy for invasive pulmonary aspergillosis","volume":"73","author":"Whitson","year":"2007","journal-title":"Am Surg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4103\/0970-2113.209232","article-title":"Video-assisted thoracoscopic surgery for pulmonary aspergilloma","volume":"34","author":"Kumar","year":"2017","journal-title":"Lung India"},{"key":"B44","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.athoracsur.2013.10.050","article-title":"Surgical therapy of pulmonary aspergillomas: a 30-year North American experience","volume":"97","author":"Muniappan","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"B45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/s0003-4975(01)03280-5","article-title":"Full thoracoscopic approach for surgical management of invasive pulmonary aspergillosis","volume":"73","author":"Gossot","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"B46","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1510\/icvts.2011.265553","article-title":"Surgery for aspergilloma: time trend towards improved results?","volume":"13","author":"Lejay","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1055\/s-2006-924623","article-title":"Favorable acute and long-term outcomes after the resection of pulmonary aspergillomas","volume":"55","author":"Okubo","year":"2007","journal-title":"Thorac Cardiovasc Surg"},{"key":"B48","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1164\/arrd.1964.89.2.186","article-title":"Bronchopulmonary aspergillosis. A correlation of the clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis","volume":"89","author":"Campbell","year":"1964","journal-title":"Am Rev Respir Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1097\/SLE.0000000000000663","article-title":"Uniportal video-assisted thoracoscopic surgery for pulmonary aspergilloma: a report of 5 cases","volume":"29","author":"Ocakcioglu","year":"2019","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0193732","DOI":"10.1371\/journal.pone.0193732","article-title":"Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis","volume":"13","author":"Bongomin","year":"2018","journal-title":"PLoS One"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1553699\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:27:13Z","timestamp":1744003633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1553699\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":50,"alternative-id":["10.3389\/fsurg.2025.1553699"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2025.1553699","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"article-number":"1553699"}}